Efficacy of polymeric encapsulated C5a peptidasebased group B streptococcus vaccines in a murine model

American Journal of Obstetrics and Gynecology

Volumn 205, Issue 3, 2011, Pages 249.e1-249.e8

  Santillan, Donna A ^a   Rai, Karishma K ^a   Santillan, Mark K ^a   Krishnamachari, Yogita ^b   Salem, Aliasger K ^b   Hunter, Stephen K ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

antigen encapsulation; C5a peptidase; group B streptococcus; microparticle; microsphere; mouse; poly(lactide coglycolide); vaccine

Indexed keywords

C5A PEPTIDASE; MICROSPHERE; PEPTIDASE; POLYGLACTIN; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; BACTERIAL COLONIZATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUP B STREPTOCOCCAL INFECTION; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; STREPTOCOCCUS AGALACTIAE;

EID: 80052269500     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2011.06.024     Document Type: Conference Paper

References (43)

1. D.L. Kasper, and C.J. Baker Electron microscopic definition of surface antigens of group B Streptococcus J Infect Dis 139 1979 147 151 (Pubitemid 9140857)
2. C.G. Whitney, S. Daly, and S. Limpongsanurak The international infections in pregnancy study: group B streptococcal colonization in pregnant women J Matern Fetal Neonatal Med 15 2004 267 274 (Pubitemid 38686017)
3. Committee to Study Priorities for Vaccine Development, Institute of Medicine Vaccines for the 21st century: a tool for decisionmaking K.D. Stratton, J.S. Durch, and R.S. Lawrence Vaccine for the 21st century: a tool for decision making 2000 National Academy Press Washington, DC
4. E.G. Wood, and H.C. Dillon Jr A prospective study of group B streptococcal bacteriuria in pregnancy Am J Obstet Gynecol 140 1981 515 520 (Pubitemid 11093131)
5. M.A. Pass, B.M. Gray, and H.C. Dillon Jr Puerperal and perinatal infections with group B streptococci Am J Obstet Gynecol 143 1982 147 152 (Pubitemid 12104983)
6. P.I. Lerner, K.V. Gopalakrishna, E. Wolinsky, M.C. McHenry, J.S. Tan, and M. Rosenthal Group B streptococcus (S agalactiae) bacteremia in adults: analysis of 32 cases and review of the literature Medicine (Baltimore) 56 1977 457 473 (Pubitemid 8229835)
7. H.O. Daugaard, A.C. Thomsen, U. Henriques, and A. Ostergaard Group B streptococci in the lower urogenital tract and late abortions Am J Obstet Gynecol 158 1988 28 31 (Pubitemid 18043329)
8. J.I. Andrews, D.J. Diekema, and S.K. Hunter Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere Am J Obstet Gynecol 183 2000 859 862
9. Prevention of perinatal group B streptococcal diseaserevised guidelines from the CDC, 2010 MMWR Recomm Rep 59 2010 1 36
10. S. Schrag, R. Gorwitz, K. Fultz-Butts, and A. Schuchat Prevention of perinatal group B streptococcal disease Revised guidelines from the CDC MMWR Recomm Rep 51 2002 1 22
11. M.D. Pearlman, C.L. Pierson, and R.G. Faix Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin Obstet Gynecol 92 1998 258 261 (Pubitemid 28350860)
12. A.M. Weisner, A.P. Johnson, and T.L. Lamagni Characterization of group B streptococci recovered from infants with invasive disease in England and Wales Clin Infect Dis 38 2004 1203 1208 (Pubitemid 38608558)
13. A. Schuchat Group B streptococcus Lancet 353 1999 51 56 (Pubitemid 29037712)
14. K.L. Kotloff, A. Fattom, L. Basham, A. Hawwari, S. Harkonen, and R. Edelman Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults Vaccine 14 1996 446 450 (Pubitemid 26153337)
15. C.J. Baker, L.C. Paoletti, and M.A. Rench Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women J Infect Dis 182 2000 1129 1138
16. S.K. Hunter, M.E. Andracki, and A.M. Krieg Biodegradable microspheres containing group B Streptococcus vaccine: immune response in mice Am J Obstet Gynecol 185 2001 1174 1179 (Pubitemid 33097383)
17. H.R. Hill, J.F. Bohnsack, and E.Z. Morris Group B streptococci inhibit the chemotactic activity of the fifth component of complement J Immunol 141 1988 3551 3556
18. J.F. Bohnsack, K.W. Mollison, A.M. Buko, J.C. Ashworth, and H.R. Hill Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus Biochem J 273 Pt 3 1991 635 640
19. J.F. Bohnsack, X.N. Zhou, P.A. Williams, P.P. Cleary, C.J. Parker, and H.R. Hill Purification of the proteinase from group B streptococci that inactivates human C5a Biochim Biophys Acta 1079 1991 222 228
20. C.C. Chen, and P.P. Cleary Complete nucleotide sequence of the streptococcal C5a peptidase gene of Streptococcus pyogenes J Biol Chem 265 1990 3161 3167
21. P.P. Cleary, J. Handley, A.N. Suvorov, A. Podbielski, and P. Ferrieri Similarity between the group B and A streptococcal C5a peptidase genes Infect Immun 60 1992 4239 4244
22. I. Chmouryguina, A. Suvorov, P. Ferrieri, and P.P. Cleary Conservation of the C5a peptidase genes in group A and B streptococci Infect Immun 64 1996 2387 2390 (Pubitemid 26226794)
23. C.K. Brown, Z.Y. Gu, and Y.V. Matsuka Structure of the streptococcal cell wall C5a peptidase Proc Natl Acad Sci USA 102 2005 18391 18396 (Pubitemid 43011236)
24. P.P. Cleary, U. Prahbu, J.B. Dale, D.E. Wexler, and J. Handley Streptococcal C5a peptidase is a highly specific endopeptidase Infect Immun 60 1992 5219 5223
25. C. Beckmann, J.D. Waggoner, T.O. Harris, G.S. Tamura, and C.E. Rubens Identification of novel adhesins from group B streptococci by use of phage display reveals that C5a peptidase mediates fibronectin binding Infect Immun 70 2002 2869 2876 (Pubitemid 34564143)
26. Q. Cheng, D. Stafslien, S.S. Purushothaman, and P. Cleary The group B streptococcal C5a peptidase is both a specific protease and an invasin Infect Immun 70 2002 2408 2413 (Pubitemid 34408382)
27. Q. Cheng, B. Carlson, and S. Pillai Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci Infect Immun 69 2001 2302 2308 (Pubitemid 32239697)
28. D.A. Santillan, M.E. Andracki, and S.K. Hunter Protective immunization in mice against group B streptococci using encapsulated C5a peptidase Am J Obstet Gynecol 198 2008 114.e1 114.e6
29. W.L. Murphy, D.H. Kohn, and D.J. Mooney Growth of continuous bonelike mineral within porous poly(lactide-co-glycolide) scaffolds in vitro J Biomed Mater Res 50 2000 50 58
30. R. Jalil, and J.R. Nixon Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties J Microencapsul 7 1990 297 325 (Pubitemid 20336774)
31. R.A. Jain The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices Biomaterials 21 2000 2475 2490
32. J. Intra, and A.K. Salem Fabrication, characterization and in vitro evaluation of poly(D,L-lactide-co-glycolide) microparticles loaded with polyamidoamine-plasmid DNA dendriplexes for applications in nonviral gene delivery J Pharmaceut Sci 99 2010 368 384
33. X.Q. Zhang, C.E. Dahle, N.K. Baman, N. Rich, G.J. Weiner, and A.K. Salem Potent antigen-specific immune responses stimulated by codelivery of CpG ODN and antigens in degradable microparticles J Immunother 30 2007 469 478 (Pubitemid 46988080)
34. R. Christie, N.E. Atkins, and E. Munch-Petersen A note on the lytic phenomenon shown by group B streptococci Aust J Exp Biol Med Sci 22 1944 197 200
35. C.R. Wira, and J. Stern Endocrine regulation of the mucosal immune system in the female reproductive tract: control of IgA, IgG, and secretory component during the reproductive cycle, at implantation and throughout pregnancy R. Pasqualini, R. Scholler, Hormones and fetal pathophysiology 1992 Marcel Dekker New York
36. X. Shen, T. Lagergard, Y. Yang, M. Lindblad, M. Fredriksson, and J. Holmgren Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine Infect Immun 68 2000 5749 5755
37. G. Xue, L. Yu, S. Li, and X. Shen Intranasal immunization with GBS surface protein Sip and ScpB induces specific mucosal and systemic immune responses in mice FEMS Immunol Med Microbiol 58 2010 202 210
38. C. Larsson, J. Holmgren, G. Lindahl, and C. Bergquist Intranasal immunization of mice with group B streptococcal protein rib and cholera toxin B subunit confers protection against lethal infection Infect Immun 72 2004 1184 1187 (Pubitemid 38166707)
39. H.H. Yang, S.J. Mascuch, L.C. Madoff, and L.C. Paoletti Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein Clin Vaccine Immunol 15 2008 1035 1041 (Pubitemid 352018316)
40. I. Santi, M. Scarselli, and M. Mariani BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood Mol Microbiol 63 2007 754 767 (Pubitemid 46105900)
41. A.L. Meinke, B.M. Senn, and Z. Visram Immunological fingerprinting of group B streptococci: from circulating human antibodies to protective antigens Vaccine 28 2010 6997 7008
42. M.S. Edwards, and C.J. Baker Group B streptococcal infections in elderly adults Clin Infect Dis 41 2005 839 847 (Pubitemid 41266752)
43. P. Kuo-Haller, Y. Cu, J. Blum, J.A. Appleton, and W.M. Saltzman Vaccine delivery by polymeric vehicles in the mouse reproductive tract induces sustained local and systemic immunity Mol Pharm 7 2010 1585 1595